Full
Outline
To evaluate the health status of residents in the chronic diseases comprehensive control and prevention demonstration areas, and provide empirical evidence for optimizing chronic disease control and prevention strategies.
Three demonstration areas established before 2014 in Jinan were selected as the research subjects, and three districts/counties without established demonstration areas were chosen as the control group for comparison. Death registration data of the registered population from 2013 to 2023 were collected, and SPSS 20.0 software was used for statistical analysis. For the first time, this study integrated healthy-adjusted life expectancy(HALE), age standardized mortality rate (ASMR), years of life lost(YLL) rate, and premature death probability with the construction of demonstration areas. Using Joinpoint regression models,the average annual percentage change(AAPC) was calculated to compare the trends between the demonstration and non-demonstration areas.
From 2013 to 2023, the HALE of residents in the demonstration areas increased from 69.20 years to 71.32 years, with an average annual increase of 0.32% (P<0.05). The ASMR decreased by an average of 1.96% per year (P<0.05). The YLL rate declined by an average of 0.92% annually (P<0.05). The premature death probability was reduced by an average of 2.22% each year (P<0.05). Among the major diseases, the ASMR, YLL rate and premature death probability of the four major malignant tumors (lung cancer, stomach cancer, liver cancer and esophageal cancer) and chronic obstructive pulmonary disease(COPD) among the residents in the demonstration areas all showed a downward trend. For ischemic heart disease(IHD), the four major malignant tumors, and COPD, the rate of decline in the premature death probability among residents in the demonstration areas was not only faster than the decline in their ASMR, but also significantly exceeded the rate of decline in the premature death probability in the non-demonstration areas. However, there was no significant downward trend in the ASMR and YLL rate for IHD, the YLL rate and premature death probability for cerebral infarction(CI), and none of the indicators for respiratory infections showed a clear declining trend.
The construction of the demonstration areas in Jinan has achieved remarkable results, especially in the prevention and control of some malignant tumors and COPD. The working-age population has benefited more. However, IHD, CI and respiratory infections will be the key points of control and prevention in the future.
26
14
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
